Using a molecular diagnosis of FH, Rubba et al. [19] identified 82% causative mutations of LDLR, APOB, and PCSK9 in young patients with a family history of hypercholesteremia or premature CAD and LDL-C ≥ 4.9 mmol/L. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.